knowcompoundsbeta-cryptoxanthin
Specimen compound organic compoundPlate I
Beta- cryptoxanthin
A mono-hydroxylated xanthophyll that is a provitamin A precursor.”

432 readings, by contour and atom
- Formula
- C40H56O
- Molar mass
- 552.887 g/mol
- ChEBI
- CHEBI:10362
- PubChem CID
- 5281235
- MeSH
- D000072743
- InChIKey
- DMASLKHVQRHNES-FKKUPVFPSA-N
↓ lowered
01 · the evidence, ordered
What the evidence says
- Moderate
Beta-cryptoxanthin
1 reference statement, not drawn · 36 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
02 · findings
What beta-cryptoxanthin moved, and by how much
- MD mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- Alanine aminotransferaseMoved: lowersEffect, as reportedMD−9.6Evidence: ModeratePaper: PMID 330817172020
- Who
- Iranian overweight/obese adults with moderate-to-severe non-alcoholic fatty liver disease; the same 500 kcal/day-deficit normal-protein diet in both arms; intention-to-treat, multivariable-adjusted ANCOVA contrast against the control arm
- Dose studied
- 6 mg/day β-cryptoxanthin, one 600 mg capsule (powder 1% β-cryptoxanthin, 99% starch) daily after dinner, 12 weeks
In addition, patients in the β-cryptoxanthin group only showed a greater 12-week reduction in serum level of ALT, compared to those in the control group (for ALT: mean difference − 9.6 IU/L; p = 0.005).”
Quoted verbatim from A hypocaloric high-protein diet supplemented with β-cryptoxanthin improves non-alcoholic fatty liver disease: a randomized controlled trial.RCT · 3 monthsPermalink
No row matches these filters.
No dose is advised.
- MD mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
03 · identity
Structure
- Charge
- 0
- SMILES
- CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C[C@@H](O)CC2(C)C)C(C)(C)CCC1
04 · reach
What it touches on the way
1 entity · assembled from reference reactions
- BCO2Protein7 paths · 7 endpointsinferred
What the reference databases state
1Reference statement
What the reference databases state
Evidence keyStatements
1 statement
beta-cryptoxanthin is a substrate of each
- ProteinRhea RHEA:68440Inferred only
4Reactions
06 · on the label · 171 products
Labelled products
Source: NIH DSLD · Ingredient: beta-cryptoxanthin · 171 products · Declared amount per serving: 8–10,000 µg
114 labels state an amount57 do not
- Bronson LaboratoriesNatural Beta Carotene112 µgper 1 softgelDSLD:8527
- Controlled LabsWhite Floodamount not statedper 6.1 gDSLD:2637
- CTD SportsMulti Eliteamount not statedper 1 tabletDSLD:270908
- DCMarine Caroteneamount not statedper 1 softgelDSLD:266113
- DCMarine Carotene1.0%amount not statedper 1 softgelDSLD:331331
- Douglas LaboratoriesOcu-Min Forteamount not statedper 6 tabletsDSLD:10104
- Douglas LaboratoriesOcu-Min Forteamount not statedper 6 tabletsDSLD:31006
- Drucker LabsintraKID All-In-One All Natural Raspberry Flavoramount not statedper 0.5 fl. Oz.DSLD:31428
- Everett LaboratoriesStrovite One Caplets Iron Freeamount not statedper 1 capletDSLD:82337
- GNCMultivitamin10 µgper 2 beige capletsDSLD:260119
- GNCWomen's Ultra Mega without Iron10 µgper 2 light green capletsDSLD:331496
- GNC AMP Advanced Muscle PerformanceMega Men Sport Multivitamin10 µgper 2 mocha brown capletsDSLD:183541
Show the remaining 159Show the first 12
Label record: NIH Office of Dietary Supplements · CC0
07 · the record
Sources
7
papers screened for beta-cryptoxanthin
- admitted
- 1
- read and discarded
- 5
- not read yet
- 1
Sources cited
1 paper · 1 finding
Show every paper citedHide the papers cited
Other names · 2
cryptoxanthin
systematic · (3R)-β,β-caroten-3-ol